Vitiligo
Vitiligo is a skin condition that causes patches of skin to lose their pigment, resulting in lighter areas. This can occur as new lesions or the extension of existing ones, often leading to noticeable changes in skin color.
Vitiligo Treatment: Methotrexate and UVB Phototherapy
We are studying whether combining methotrexate with UVB phototherapy helps adults with progressive vitiligo achieve better skin repigmentation. We will also assess the safety of this treatment and its impact on quality of life.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you over 18 years old?
- Do you have non-segmental vitiligo with at least 10% of your body affected?
- Are you currently pregnant or breastfeeding?
- Have you had any serious infections that required hospitalization in the last 4 weeks?
- Are you taking any medications that could interfere with methotrexate, like certain blood thinners or immunosuppressants?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Microcrystalline Cellulose
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Hospitalier Universitaire De Bordeaux
Dermatologie de l’Adulte et de l’Enfant
Bordeaux, France
Centre Hospitalier De Pau
Dermatologie
Pau, France
Centre Hospitalier De Perigueux
Dermatologie
Périgueux, France
Sponsor: Centre Hospitalier Universitaire De Bordeaux
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.